Skip to main content
. 2018 Mar 13;7(4):e1408744. doi: 10.1080/2162402X.2017.1408744

Figure 2.

Figure 2.

Overview of combination PD-1/PD-L1 trials. A, number of trials listed according to number of therapies combined with PD-1/PD-L1 blockade (e.g. trials with 2 combination therapies add 2 additional agents to PD-1/PD-L1 blockade). B, number of combination trials grouped broadly by treatment modality/mechanism of action.